Akèy › Kansè pwostat › Arizona › Scottsdale
Etid klinik pou Kansè pwostat nan Scottsdale, AZ
17 etid pou Kansè pwostat ap chèche patisipan nan sit nan ak bò kote Scottsdale (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Radiation Therapy With RapidPlan Knowledge-based Planning vs Human-Driven Planning for Treatment of Prostate Cancer
Ap rekriteFaz 3
- Mayo Clinic in Arizona, Scottsdale
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Ap rekriteFaz 2
- Mayo Clinic in Arizona, Scottsdale
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
Ap rekriteFaz 3
- Mayo Clinic, Scottsdale
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Ap rekriteFaz 3
- Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers, Scottsdale
Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial
Ap rekriteFaz 2
- Mayo Clinic in Arizona, Scottsdale
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Ap rekriteFaz 2/3
- Honor Health Research Institute, Scottsdale
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Ap rekrite
- Mayo Clinic, Scottsdale
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
Ap rekriteFaz 1
- HonorHealth, Scottsdale
A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
Ap rekriteFaz 1/2
- Honor Health Research Institute, Scottsdale
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Ap rekriteFaz 2
- HonorHealth Research Institute, Scottsdale
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1/2
- Honor Health, Scottsdale
Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients
Ap rekriteFaz 1 bonè
- Mayo Clinic in Arizona, Scottsdale
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer
Ap rekriteFaz 1/2
- Honor Health, Scottsdale
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Ap rekriteFaz 4
- Mayo Clinic Arizona, Scottsdale
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Ap rekriteFaz 1
- HonorHealth Research Institute, Scottsdale
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Ap rekriteFaz 4
- Scottsdale Medical Imaging, LLC, Scottsdale
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Scottsdale
Etid Kansè pwostat nan lòt vil
- New York City, NY103 etid
- Houston, TX76 etid
- Los Angeles, CA61 etid
- Boston, MA59 etid
- St. Louis, MO46 etid
- Chicago, IL45 etid
- San Francisco, CA45 etid
- Philadelphia, PA44 etid
- Baltimore, MD43 etid
- Nashville, TN42 etid
- Seattle, WA42 etid
- Washington, DC38 etid
Lòt etid nan Scottsdale
- Kansè (tout kalite)18 etid
- Kansè nan tete18 etid
- Kansè Metastatik17 etid
- Kansè Poumon ki pa ti selil15 etid
- Kansè kolorektal15 etid
- Kansè pankreyas13 etid
- Melanom10 etid
- Kolit Ulseratif8 etid
- Kansè poumon8 etid
- Maladi Alzheimer7 etid
- Kansè fwa (Kasinòm epatoselilè)7 etid
- Kansè tete negatif triple7 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.